Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical trials among patients with presbyopia. Tenpoint Therapeutics announced the ...
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea Submission of New Drug Application (NDA) in South ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback